Category: 3. Business

  • Republic of Colombia – Announcement of Offer to Purchase Old Bonds

    BOGOTA, Colombia, Nov. 14, 2025 /PRNewswire/ — Colombia announced today the commencement of an offer to purchase for cash (the “Offer“) from each registered holder or beneficial owner (each, a “Holder” and, collectively, the “Holders“) the outstanding bonds of the series set forth in the table below (collectively, the “Old Bonds“), such that the maximum amount to be paid for the Old Bonds validly tendered and accepted for purchase pursuant to the Offer, not including interest accrued and unpaid thereon, is to be determined by Colombia in its sole discretion (such amount for each series, the “Maximum Purchase Amount“).  The terms and conditions of the Offer are set forth in the offer document, dated November 14, 2025 (the “Offer Document“), including the borrowing or issuance of debt and receipt of funds by Colombia (the “Financing Condition“).

    Subject to the Financing Condition, the Offer is not conditioned upon any minimum participation of any series of the Old Bonds.

    The purchase price to be paid per U.S.$1,000, €1,000, Ps. 1,000 principal amount of each series of Old Bonds, as applicable, that are accepted pursuant to the Offer will be an amount equal to the fixed price indicated in the table below (such amount for each series, the “Purchase Price“). In addition to the Purchase Price, Holders whose Old Bonds are accepted for purchase in the Offer will also receive any accrued and unpaid interest from, and including, the last interest payment date for such Old Bonds up to, but excluding, the Settlement Date (as defined below) (the “Accrued Interest“). If the aggregate Purchase Price for all validly tendered Old Bonds of a series would exceed the Maximum Purchase Amount, then Colombia will, in its sole discretion, apply a proration factor to the Tenders (as defined below).


                          Old Bonds







    Old Bonds

    Outstanding Principal
    Amount as of November
    14, 2025

    Security Identifier

    Fixed Purchase Price(1)

    3.875% Global Bonds due 2026 (the “EUR
    2026 Global Bonds
    “)

    €634,893,000

    ISIN: XS1385239006

    Common Code: 138523900

    € 1,005.71

    9.850% Global TES Bonds due 2027 (the
    COP 2027 Global Bonds“, and together
    with the EUR 2026 Global Bonds, the
    Non-U.S. Dollar Bonds“)

    Ps.1,924,515,000,000

    ISIN: XS0306322065

    Common Code: 030632206

    Ps. 1,000.00

    3.875% Global Bonds due 2027

    U.S.$1,740,144,000

    CUSIP: 195325DL6

    ISIN: US195325DL65

    $1,000.00

    4.500% Global Bonds due 2029

    U.S.$2,000,000,000

    CUSIP: 195325DP7

    ISIN: US195325DP79

    $1,000.00

    3.000% Global Bonds due 2030

    U.S.$1,542,968,000

    CUSIP: 195325DR3

    ISIN: US195325DR36

    $918.75

    7.375% Global Bonds due 2030

    U.S.$1,900,000,000

    CUSIP: 195325 ER2

    ISIN: US195325ER27

    $1,086.25

    10.375% Global Bonds due 2033

    U.S.$340,511,000

    CUSIP: 195325BB0

    ISIN: US195325BB02

    $1,277.50

    8.000% Global Bonds due 2033

    U.S.$1,624,241,000

    CUSIP: 195325EF8

    ISIN: US195325EF88

    $1,127.50

    7.500% Global Bonds due 2034

    U.S.$2,200,000,000

    CUSIP: 195325EG6

    ISIN: US195325EG61

    $1,087.50

    8.500% Global Bonds due 2035

    U.S.$1,900,000,000

    CUSIP: 195325 ES0

    ISIN: US195325ES00

    $1,160.00

    8.000% Global Bonds due 2035

    U.S.$1,900,000,000

    CUSIP: 195325EL5

    ISIN: US195325EL56

    $1,117.50

    7.750% Global Bonds due 2036

    U.S.$2,000,000,000

    CUSIP: 195325EP6

    ISIN: US195325EP60

    $1,090.00

    7.375% Global Bonds due 2037

    U.S.$1,818,400,000

    CUSIP: 195325BK0

    ISIN: US195325BK01

    $1,066.25

    6.125% Global Bonds due 2041

    U.S.$2,500,000,000

    CUSIP:195325BM6

    ISIN: US195325BM66

    $928.75

    5.000% Global Bonds due 2045

    U.S.$3,670,948,000

    CUSIP: 105325CU7

    ISIN: US105325CU73

    $787.50

    8.750% Global Bonds due 2053

    U.S.$1,900,000,000

    CUSIP: 195325EM3

    ISIN: US195325EM30

    $1,192.50

    8.375% Global Bonds due 2054 (together
    with the other U.S. dollar denominated
    bonds listed above, the “U.S. Dollar
    Bonds
    “)

    U.S.$1,640,000,000

    CUSIP: 195325EQ4

    ISIN: US195325EQ44

    $1,147.50



    (1)

    Per $1,000 for the U.S. Dollar Bonds per €1,000 for the EUR 2026 Global Bonds and per Ps.1,000 for the COP 2027 Global Bonds.

    (2)

    In the case of the COP 2027 Global Bonds, the Purchase Price and related accrued interest will be paid in U.S. dollars, in an amount determined by converting the Purchase Price and related accrued interest to U.S. dollars at a currency exchange rate equal to the “Representative Market Rate” in effect as of 2:00 p.m., New York City time, on the U.S. business day prior to the Non-U.S. Dollar Bonds Tender Period Expiration Time  as calculated and published by the Financial Superintendency of Colombia, and which is available on Bloomberg by typing “COP TRM CurncyHP” or at the Financial Superintendency’s  website at https://www.superfinanciera.gov.co/publicaciones/60819/informes-y-cifrascifrasestablecimientos-de-creditoinformacion-periodicadiariatasa-de-cambio-representativa-del-mercado-trm-60819/.

    Old Bonds may be tendered only in principal amounts equal to the minimum authorized denomination and integral multiples thereof, as set forth below for each series of Old Bonds (the “Minimum Denomination“). Holders who tender less than all of their Old Bonds must continue to hold Old Bonds in at least the Minimum Denomination.

    In determining the amount of Old Bonds to be purchased against the Maximum Purchase Amount and available for purchases pursuant to the Offer, the aggregate U.S. dollar-equivalent purchase price of (i) the EUR 2026 Global Bonds shall be calculated at the exchange rate for the Euro to U.S. Dollar, as of 2:00 p.m., New York City time, on the U.S. business day prior to the Non-U.S. Dollar Bonds Tender Period Expiration Time (as defined below), as reported on Bloomberg screen page “FXIP” under the heading “FX Rate vs. USD” (or, if such screen is unavailable, a generally recognized source for currency quotations selected by Colombia with quotes as of a time as close as reasonably possible to the aforementioned), and (ii) the COP 2027 Global Bonds, shall be calculated at the exchange rate equal to the “Representative Market Rate” in effect as of 2:00 p.m., New York City time, on the U.S. business day prior to the Non-U.S. Dollar Bonds Tender Period Expiration Time  as calculated and published by the Financial Superintendency of Colombia, and which is available on Bloomberg by typing “COP TRM CurncyHP” or at the Financial Superintendency’s  website at https://www.superfinanciera.gov.co/publicaciones/60819/informes-y-cifrascifrasestablecimientos-de-creditoinformacion-periodicadiariatasa-de-cambio-representativa-del-mercado-trm-60819/.

    Old Bonds

    Minimum Authorized Denominations

    3.875% Global Bonds due 2026

    €100,000 and integral multiples of €1,000 in excess thereof

    9.850% Global TES Bonds due 2027

    Ps. 5,000,000 and integral multiples of Ps. 1,000,000 in excess thereof

    3.875% Global Bonds due 2027

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    4.500% Global Bonds due 2029

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    7.375% Global Bonds due 2030

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    3.000% Global Bonds due 2030

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    10.375% Global Bonds due 2033

    U.S.$1,000 and integral multiples of U.S.$1,000 in excess thereof

    8.000% Global Bonds due 2033

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    7.500% Global Bonds due 2034

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    8.500% Global Bond due 2035

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    8.000% Global Bonds due 2035

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    7.750% Global Bonds due 2036

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    7.375% Global Bonds due 2037

    U.S.$100,000 and integral multiples of U.S.$1,000 in excess thereof

    6.125% Global Bonds due 2041

    U.S.$100,000 and integral multiples of U.S.$1,000 in excess thereof

    5.000% Global Bonds due 2045

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    8.750% Global Bonds due 2053

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    8.375% Global Bonds due 2054

    U.S.$200,000 and integral multiples of U.S.$1,000 in excess thereof

    Colombia reserves the right, in its sole discretion, not to accept any valid orders to tender any series of Old Bonds in accordance with the terms and conditions of the Offer (“Tenders“), subject to applicable law, to increase or decrease the Purchase Price for any series of the Old Bonds, or to terminate the Offer for any reason. In the event of a termination of the Offer, the tendered Old Bonds will be returned to the tendering Holder.

    If Colombia accepts all or a portion of a Holder’s Tender, the Holder will be entitled to receive for such Old Bonds the applicable Purchase Price plus Accrued Interest, which will be paid on the Settlement Date (as defined below), if the conditions of the Offer are met.

    The Offer commenced on Friday, November 14, 2025.  Unless extended or earlier terminated in Colombia’s sole discretion, the Offer will expire at (i) 5:00 p.m., New York City time, on Wednesday, November 19, 2025 for U.S. Dollar Bonds (the “U.S. Dollar Bonds Tender Period Expiration Time“) and (ii) 5:00 p.m., New York City time, on Friday, November 21, 2025 for Non-U.S. Dollar Bonds (the “Non-U.S. Dollar Bonds Tender Period Expiration Time“).  In the event that the Offer to purchase U.S. Dollar Bonds or Non-U.S. Dollar Bonds is extended or earlier terminated, the terms “U.S. Dollar Bonds Tender Period Expiration Time” and “Non-U.S. Dollar Bonds Tender Period Expiration Time” shall mean the time and date on which such Offer, as so extended or earlier terminated, shall expire. The settlement of the Offer is scheduled to occur on Wednesday, November 26, 2025 (the “Settlement Date“). 

    The Old Bonds are held in book-entry form through either the facilities of The Depository Trust Company (“DTC“) or held in book-entry form through the facilities of Clearstream Banking, société anonyme (“Clearstream“), Euroclear Bank S.A./N.V., as operator of the Euroclear System (“Euroclear,” and together with DTC and Clearstream referred to herein as a “Covered Clearing System” and, collectively, as the “Covered Clearing Systems“). In the event of a termination of the Offer, the Old Bonds tendered pursuant to the Offer will be credited to the Holder through the relevant Covered Clearing System.

    You are advised to consult with the broker, dealer, bank, custodian, trust company, or other nominee through which you hold your Old Bonds as to the deadlines by which such intermediary would require receipt of instruction from you to participate in the Offer in accordance with the terms and conditions of the Offer as described in the Offer Document in order to meet the deadlines set forth in the Offer Document. The deadlines set by DTC, Euroclear, Clearstream, or any such intermediary for the submission of Old Bonds may be earlier than the relevant deadlines specified in the Offer Document. The acceptance of any Tenders forwarded to DTC from Euroclear or Clearstream after the Non-U.S. Dollar Tender Period Expiration Time or U.S. Dollar Tender Period Expiration Time, as the case may be, will be in the sole discretion of Colombia.

    The complete terms and conditions of the Offer are set forth in the Offer Document, together with any amendments or supplements thereto, which Holders are urged to read carefully before making any decision with respect to the Offer. 

    Global Bondholder Services Corporation is serving as the tender agent and the information agent in connection with the Offer (the “Tender and Information Agent“), and the Offer Document may be downloaded from the Tender and Information Agent’s website https://www.gbsc-usa.com/colombia/ or obtained from the Tender and Information Agent at the contact below:

    Contact information:                 

    Global Bondholder Services Corporation                                                                            

    Attention: Corporate Actions

    65 Broadway – Suite 404

    New York, New York 10006

    Attn: Corporate Actions

    Banks and Brokers call: +1 (212) 430-3774

    Toll free +1 (855) 654-2015

    E-mail: [email protected]  

    , or from the Dealer Managers.

    The dealer managers (the “Dealer Managers“) for the Offer are:

    Goldman Sachs & Co. LLC

    Attention: Liability Management  

    200 West Street, New York

    New York 10282-2198

    Toll Free: +1 (800) 828-3182

    Collect: +1 (212) 357-1452

     

    J.P. Morgan Securities LLC

    Attention: Latin America Debt
    Capital Markets  

    270 Park Avenue

    New York, New York 10017

    United States of America

    Toll Free: +1 (866) 846-2874

    Collect: +1 (212) 834-7279

     

    Santander U.S. Capital Markets LLC

    Attention: Liability Management

    437 Madison Avenue

    New York, New York 10022

    United States of America

    U.S. Toll Free: (855) 404-3636

    U.S. Collect: (212) 350-0660

    Email (U.S.): [email protected]

    Email (Europe) (Banco Santander, S.A.):
    [email protected]   
     

    Questions regarding the Offer may be directed to and the Offer Document may be obtained from the Dealer Managers at the above contact information.

    Republic of Colombia
    Ministerio de Hacienda y Crédito Público
    Dirección General de Crédito Público y Tesoro Nacional
    Carrera 8, No. 6C-38, Piso 1
    Bogotá D.C., Colombia 

    For press inquiries:

    Contact:  Javier Andrés Cuéllar Sánchez
    E-mail: [email protected]
    Call: (57) 601 3811700  Ext 3126

    Important Notice

    This announcement is not an offer to purchase or a solicitation of an offer to sell the Old Bonds. The Offer will be made only by and pursuant to the terms of the Offer Document, as may be amended or supplemented from time to time.

    The distribution of materials relating to the Offer, and the transactions contemplated by the Offer, may be restricted by law in certain jurisdictions.  The Offer is made only in those jurisdictions where it is legal to do so. The Offer is void in all jurisdictions where they are prohibited. If materials relating to the Offer come into your possession, you are required to inform yourself of and to observe all of these restrictions.  Each person accepting the Offer shall be deemed to have represented, warranted and agreed (in respect of itself and any person for whom it is acting) that it is not a person to whom it is unlawful to make the Offer pursuant to the Offer Document, it has not distributed or forwarded the Offer Document or any other documents or materials relating to the Offer to any such person, and that it has complied with all laws and regulations applicable to it for purposes of participating in the Offer. Neither Colombia nor any Dealer Manager accepts any responsibility for any violation by any person of the restrictions applicable in any jurisdiction.

    The materials relating to the Offer do not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If a jurisdiction requires that the Offer be made by a licensed broker or dealer and a Dealer Manager or any affiliate of a Dealer Manager is a licensed broker or dealer in that jurisdiction, the Offer, as the case may be, shall be deemed to be made by any Dealer Manager or such affiliate in that jurisdiction. Owners who may lawfully participate in the Offer in accordance with the terms thereof are referred to as “holders.”

    SOURCE Republic of Colombia

    Continue Reading

  • RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders – Business Wire

    1. RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders  Business Wire
    2. RPTX: Acquisition by XenoTherapeutics announced; $11.6M revenue and $3.3M net income for the quarter  TradingView
    3. Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders  Morningstar
    4. XenoTherapeutics to acquire Repare Therapeutics for $1.82 per share  Investing.com
    5. Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.  Investing News Network

    Continue Reading

  • How Tencent’s (TCEHY) AI Strength And Carbon Credit Plans Shape Its Growth Outlook

    How Tencent’s (TCEHY) AI Strength And Carbon Credit Plans Shape Its Growth Outlook

    Tencent Holdings Ltd. (OTC:TCEHY) is among the most fantastic stocks every investor should pay attention to. In a November 7 report, Bloomberg said that sustained momentum in AI development should help the company to report strong earnings for the third quarter. Moreover, results from Tencent and its peers were expected to indicate progress and standing in the AI landscape amid the rising rivalry with the U.S.

    On November 13, the company reported better-than-expected results with revenue surging 15% year-over-year to RMB 192.9 billion, and operating profit rising 19% to RMB 63.6 billion. Both of these came in ahead of the consensus of RMB 189.2 billion and RMB 58.01 billion, as per LSEG data, respectively. As was expected, investments in AI supported the topline growth with strong performance in gaming and marketing services, driven by AI-powered gaming engagement and ad targeting. Operating margin also improved by 100 basis points YoY to 33% (on IFRS basis). With strong topline growth and improved margins, EPS rose 20% to RMB 6.779.

    Another development that is gaining traction amid the ongoing COP30 climate summit in Brazil is Tencent’s preparation for an alliance of carbon credit buyers. On Wednesday, November 12, Bloomberg reported that the company is in discussions with mostly Asian firms from the manufacturing, technology, and consumer sectors to create a consortium that can buy carbon credits.

    Ella Wang, a senior program director at Tencent, said that the company needs to purchase spot and forward carbon credits to offset its emissions and to expedite its target to become carbon neutral. The alliance described above would create more demand. Ella further elaborated:

    “We believe it would send a signal to the market and encourage more potential suppliers, especially in the Global South countries.” She also said, “Such an alliance would benefit the companies in many respects, including helping with compliance and technology adoption”.

    Tencent Holdings Ltd. (OTC:TCEHY) is a leading Chinese multinational technology conglomerate specializing in internet-related services, entertainment, and artificial intelligence.

    While we acknowledge the potential of TCEHY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

    READ NEXT:  13 Best Stocks to Buy According to Citadel LLC and Goldman Sachs Defense Stocks: Top 10 Stocks to Buy.

    Disclosure: None. This article is originally published at Insider Monkey.

    Continue Reading

  • Apple intensifies succession planning for CEO Tim Cook

    Apple intensifies succession planning for CEO Tim Cook

    Unlock the Editor’s Digest for free

    Apple is stepping up its succession planning efforts, as it prepares for Tim Cook to step down as chief executive as soon as next year.

    Several people familiar with discussions inside the tech group told the Financial Times that its board and senior executives have recently intensified preparations for Cook to hand over the reins at the $4tn company after more than 14 years.

    John Ternus, Apple’s senior vice-president of hardware engineering, is widely seen as Cook’s most likely successor, although no final decisions have been made, these people said.

    People close to Apple say the long-planned transition is not related to the company’s current performance, ahead of what is expected to be a blockbuster end-of-year sales period for the iPhone.

    Apple declined to comment.

    The company is unlikely to name a new CEO before its next earnings report in late January, which covers the critical holiday period.

    An announcement early in the year would give its new leadership team time to settle in ahead of its big annual keynote events, its developer conference in June and its iPhone launch in September, the people said.

    These people said that although preparations have intensified, the timing of any announcement could change.

    Cook, Apple’s former operations chief who turned 65 this month, has led the company since 2011 when he took over the role from its co-founder Steve Jobs, who died months later. During Cook’s tenure, the Big Tech group’s market capitalisation has surged from about $350bn in 2011 to $4tn today.

    Apple’s shares are trading close to an all-time high after strong results last month, although its stock-price rise of roughly 12 per cent this year lags behind its Big Tech rivals Alphabet, Nvidia and Microsoft, whose valuations have been propelled by Wall Street’s exuberance about artificial intelligence.

    Apple has had a number of high-profile changes this year among its top executive team. Longtime Cook confidante, chief financial officer Luca Maestri, stepped back from his role at the start of this year. Jeff Williams, a Cook protégé, announced he was stepping down as chief operating officer in July.

    Appointing Ternus would put an executive from the hardware side of the company back in charge at the iPhone maker at a time when Apple has struggled to break into new product categories and keep up with its Silicon Valley rivals in AI.

    Cook has voiced his preference for an internal candidate to be chosen as his replacement, saying the company has “very detailed succession plans”.

    “I love it there and I can’t envision my life without being there so I’ll be there a while,” he told singer Dua Lipa on her podcast in November 2023.

    Continue Reading

  • Why Ascletis Pharma (SEHK:1672) Is Up 45.4% After Unveiling New Obesity Drug Data and US IND Plans

    Why Ascletis Pharma (SEHK:1672) Is Up 45.4% After Unveiling New Obesity Drug Data and US IND Plans

    • Ascletis Pharma announced new preclinical and Phase Ib clinical results for its portfolio of next-generation obesity drug candidates, including ASC36, ASC35, and ASC30, developed using its proprietary AISBDD and ULAP technologies.

    • A key highlight is the plan to submit a US Investigational New Drug Application in 2026 for a co-formulated monthly therapy that showed greater weight reduction in animal models compared to existing treatments.

    • We’ll explore how Ascletis Pharma’s advancement toward a US IND submission for its obesity treatment candidates could reshape its investment narrative.

    AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.

    For investors considering Ascletis Pharma, the core belief hinges on the company’s ability to break into the high-growth obesity treatment market with its new-generation drug candidates. The recent disclosure of strong preclinical and Phase Ib data for ASC36, ASC35, and ASC30, along with a planned US IND application for a co-formulated monthly obesity therapy, marks a potentially significant catalyst that could refresh sentiment and drive near-term share price momentum. This news adds clear visibility to the clinical pipeline, which has repeatedly faced skepticism due to historic unprofitability and regulatory hurdles. While the obesity portfolio’s progress could accelerate prospects and broaden Ascletis’ market appeal, key risks remain, especially related to clinical trial outcomes and the heavy investment demands required before potential commercialisation. Materially, these developments could shift attention from past earnings volatility toward future pipeline milestones as primary value drivers.

    On the flip side, regulatory outcomes and patent risks remain critical concerns for shareholders. Upon reviewing our latest valuation report, Ascletis Pharma’s share price might be too optimistic.

    SEHK:1672 Earnings & Revenue Growth as at Nov 2025

    The Simply Wall St Community offered one fair value estimate before this latest news event, suggesting very little variation in opinions at that time. While clinical trial advancements have improved pipeline visibility, actual commercial success depends on regulatory approvals and market uptake. Explore other views that may broaden your perspective on what could shape the company’s future.

    Explore another fair value estimate on Ascletis Pharma – why the stock might be worth less than half the current price!

    Disagree with this assessment? Create your own narrative in under 3 minutes – extraordinary investment returns rarely come from following the herd.

    These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include 1672.HK.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Valuation Insights After Earnings Beat and New Wireless Power Partnership

    Valuation Insights After Earnings Beat and New Wireless Power Partnership

    MDA Space (TSX:MDA) is making headlines after two major updates for investors: robust earnings for the quarter and year to date, along with a new partnership to advance wireless power systems for use in space.

    See our latest analysis for MDA Space.

    The share price has had a turbulent ride this year, with a sharp dip in recent months weighing on sentiment. Positive earnings and partnership news made headlines during this period. While the year-to-date share price return stands at -21.87%, long-term investors have still pocketed a 238.3% total shareholder return over the past three years. This points to significant gains for those who have stayed the course.

    Curious what else is happening in the sector? You can explore other aerospace and defense innovators with strong momentum by checking out See the full list for free.

    MDA Space’s recent results and high-profile partnership have caught investor attention, but with shares still well below analyst targets and strong revenue gains, is this a bargain opportunity or is future growth already priced in?

    According to IndusyHoldings, the narrative puts MDA Space’s fair value at CA$44.08, nearly double the recent close. This sets the stage for an ambitious financial outlook.

    MDA Space can benefit greatly from the tailwind of the industry as they offer a wide product range that includes LEO and MEO satellites, space robots and space rovers.

    Read the complete narrative.

    What’s the growth blueprint fueling that target price? The narrative’s secret sauce lies in bold projections about future revenue and profit margins. Want to know which key financial figures put this company in the spotlight? The full story breaks down the ambitious numbers that build this valuation case. Read on to see what’s driving it.

    Result: Fair Value of $44.08 (UNDERVALUED)

    Have a read of the narrative in full and understand what’s behind the forecasts.

    However, heavy reliance on government contracts and potential Artemis delays could quickly overturn the optimistic outlook presented by current projections.

    Find out about the key risks to this MDA Space narrative.

    If you want to dig deeper or see things differently, you can analyze the data for yourself and shape your own view in just a few minutes. Do it your way

    A great starting point for your MDA Space research is our analysis highlighting 5 key rewards and 1 important warning sign that could impact your investment decision.

    Outsmart the ordinary by tapping into opportunities others might miss. Make your next move count by finding well-positioned stocks with just a few quick clicks below.

    Continue Reading

  • Investors in Pos Malaysia Berhad (KLSE:POS) have unfortunately lost 69% over the last five years

    Investors in Pos Malaysia Berhad (KLSE:POS) have unfortunately lost 69% over the last five years

    While it may not be enough for some shareholders, we think it is good to see the Pos Malaysia Berhad (KLSE:POS) share price up 25% in a single quarter. But that doesn’t change the fact that the returns over the last half decade have been disappointing. In fact, the share price has declined rather badly, down some 69% in that time. So is the recent increase sufficient to restore confidence in the stock? Not yet. We’d err towards caution given the long term under-performance.

    Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they’ve been consistent with returns.

    Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments that are poised to benefit.

    Pos Malaysia Berhad isn’t currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That’s because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

    You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

    KLSE:POS Earnings and Revenue Growth November 15th 2025

    This free interactive report on Pos Malaysia Berhad’s balance sheet strength is a great place to start, if you want to investigate the stock further.

    It’s good to see that Pos Malaysia Berhad has rewarded shareholders with a total shareholder return of 20% in the last twelve months. That certainly beats the loss of about 11% per year over the last half decade. This makes us a little wary, but the business might have turned around its fortunes. It’s always interesting to track share price performance over the longer term. But to understand Pos Malaysia Berhad better, we need to consider many other factors. Take risks, for example – Pos Malaysia Berhad has 3 warning signs we think you should be aware of.

    Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

    Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Malaysian exchanges.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Continue Reading

  • Tracking Warren Buffett’s Berkshire Hathaway Portfolio – Q3 2025 Update (NYSE:BRK.A) – Seeking Alpha

    Tracking Warren Buffett’s Berkshire Hathaway Portfolio – Q3 2025 Update (NYSE:BRK.A) – Seeking Alpha

    1. Tracking Warren Buffett’s Berkshire Hathaway Portfolio – Q3 2025 Update (NYSE:BRK.A)  Seeking Alpha
    2. 24.7% of Warren Buffett’s $315 billion portfolio at Berkshire Hathaway is invested in these 2 unstoppable stocks  The Motley Fool Australia
    3. 3 Buffett-Like Stocks for Your Short List  Zacks Investment Research
    4. 1 Warren Buffett Stock to Buy Hand Over Fist in November  The Motley Fool
    5. 3 Warren Buffett Stocks to Buy After Berkshire’s Latest 13F Update  Morningstar

    Continue Reading

  • Listed firms on China’s STAR market show growth momentum amid hard tech push-Xinhua

    BEIJING, Nov. 15 (Xinhua) — Firms listed on China’s Nasdaq-style Science and Technology Innovation Board, also known as the STAR Market, have shown growth resilience and high-quality development with hard technology playing a pivotal role in the first three quarters of 2025, according to the quarterly reports of the companies.

    During the period, STAR Market companies achieved operating revenue of 1.11 trillion yuan (about 156.02 billion U.S. dollars), a year-on-year increase of 7.9 percent. Their net profit reached 49.27 billion yuan, with a year-on-year growth of 8.9 percent.

    These companies achieved a significant year-on-year increase of 75 percent in net profit in the third quarter, demonstrating a strong momentum of development.

    In the first nine months, over 70 percent of the companies achieved revenue growth, and nearly 60 percent of them recorded net profit growth. Some 158 companies saw their net profit increase by more than 50 percent and 46 companies turned losses into profits.

    The reports show that the hard technology sector — including integrated circuits, chip design, artificial intelligence, biomedicine and new energy companies — has shown a thriving trend, driven by reform efforts and robust R&D expenditure.

    In the integrated circuit industry, the total 121 enterprises achieved a year-on-year increase of 25 percent in combined operating revenue and a year-on-year growth of 67 percent in combined net profit in the first three quarters.

    In the chip design sector, benefiting from the boost in downstream demand, 80 percent of enterprises achieved revenue growth and 60 percent saw net profit growth during the period, with an overall year-on-year net profit increase of 141 percent.

    The total R&D investment of STAR Market companies reached 119.75 billion yuan, 2.4 times the board’s net profit, with a median R&D intensity of 12.4 percent — remaining significantly higher than other sectors of the A-share market.

    The China Securities Regulatory Commission (CSRC), the country’s securities regulator, announced the setting up of the sci-tech growth tier on June 18 this year, with an aim to provide better support for high-quality tech enterprises that were not yet profitable.

    Since June, the STAR Market has been steadily advancing reforms, including the pilot introduction of senior professional institutional investors and pre-review mechanisms.

    Industry experts believe that with sustained policy implementation and the steady release of enterprises’ internal growth drivers, the STAR Market is poised to cultivate more leading hard technology enterprises and further advance China’s drive for high-level technological self-reliance.

    Continue Reading

  • Analyzing Market Optimism Versus Fundamentals After Recent Pullback

    Analyzing Market Optimism Versus Fundamentals After Recent Pullback

    Arm Holdings (ARM) recently reported annual results, showing double-digit growth in both revenue and net income. The company’s latest earnings update gives investors more concrete insight into how demand for its chip designs is impacting the bottom line.

    See our latest analysis for Arm Holdings.

    Even with robust annual growth fueling optimism, Arm Holdings’ share price has taken a breather lately, slipping 18.1% over the last month but still maintaining a respectable 9.0% year-to-date share price return. Investors seem undecided whether current demand and momentum are enough to drive the next leg higher, but the company’s 8.6% total shareholder return over the past year hints that the big picture remains encouraging for those with patience.

    If the action around semiconductor stocks has your attention, it could be the perfect time to explore the full landscape of innovation and performance with our tech and AI stocks screener: See the full list for free.

    So is Arm Holdings offering a rare buying opportunity with its recent pullback, or has the market already factored in all of its anticipated growth, leaving little room for upside?

    The current narrative from jaikhom pegs Arm Holdings’ intrinsic fair value at just half the prevailing share price, spotlighting a dramatic difference between market enthusiasm and fundamental estimates. Recent trading momentum and the gap to the fair value demand a closer look at what’s fueling price action.

    Based on a forward earnings framework anchored to the 10-year U.S. Treasury yield, the stock’s intrinsic fair value is estimated at $70 per share. Applying a prudent 20% discount to reflect interest rate risk and macro uncertainty yields a conservative, risk-adjusted target of $56. However, recent market action suggests investor sentiment has shifted decisively beyond fundamentals. With ARM now trading in the $120 to $140 range, its implied earnings yield has fallen below that of the 10-year Treasury, which is often seen as a hallmark of speculative enthusiasm.

    Read the complete narrative.

    Can you spot the surprising assumptions behind this eye-catching valuation gap? The forecast hinges on benchmarks that most investors ignore, plus a risk adjustment few consider. Wonder how macro forces shape this price target and the profit multiples underlying it? Uncover the bold logic and see what could be missing from the consensus view.

    Result: Fair Value of $70 (OVERVALUED)

    Have a read of the narrative in full and understand what’s behind the forecasts.

    However, surprising earnings strength or a swift change in interest rates could quickly challenge this cautious valuation outlook.

    Find out about the key risks to this Arm Holdings narrative.

    Of course, if this perspective does not align with your own, you can always dig into the numbers yourself and craft a narrative from your findings in just a few minutes. Do it your way

    A good starting point is our analysis highlighting 2 key rewards investors are optimistic about regarding Arm Holdings.

    Unlock even more opportunities. There is a world of compelling stocks out there, and the best time to uncover your next winner is right now.

    • Amplify your portfolio’s income potential with these 16 dividend stocks with yields > 3%, highlighting companies offering consistent yields above 3% and solid fundamentals that can withstand market turbulence.

    • Get ahead of market-moving innovations and spot emerging leaders by searching these 25 AI penny stocks at the intersection of artificial intelligence, automation, and real-world business solutions.

    • Seize the upside in unconventional industries. Select these 82 cryptocurrency and blockchain stocks to see which blockchain pioneers are transforming how transactions, digital assets, and networks power global growth.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include ARM.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading